文献速递肝胆胰外科围术期管理与 ERAS

高BMI患者腹腔镜与开腹大范围肝切除的倾向性评分匹配分析

Operative and long-term oncologic outcomes of laparoscopic versus open major liver resection in patients with a high body mass index (> 25 kg/m2): a propensity score matching analysis.
PubMed 文献 · Surg Endosc · 2022-03-17

结果显示腹腔镜组出血量更少、术后住院时间更短,非肝脏特异性并发症更少,但总体并发症无显著差异;在肝细胞癌亚组中,两组总生存和无复发生存均无显著差异。结论认为肥胖不应被视为腹腔镜大范围肝切除的禁忌证,但对BMI>30 kg/m²且合并症多的恶性肿瘤患者需特别注意并发症可能。

要点

  • 高BMI患者中,腹腔镜大范围肝切除较开腹手术出血量更少、术后住院时间更短。
  • 腹腔镜组非肝脏特异性并发症更少,但总体并发症两组无显著差异。
  • 肝细胞癌亚组中,腹腔镜与开腹手术的总生存和无复发生存均无显著差异。

核心结论

  • 肥胖不应被视为腹腔镜大范围肝切除术的禁忌证;但对于BMI>30 kg/m²且合并疾病的恶性肿瘤患者,行腹腔镜手术时需特别注意并发症的可能。

主要发现

  • 腹腔镜大范围肝切除组较开腹组出血量更低、术后住院时间更短(p < 0.001)。
  • 总体并发症两组无显著差异(p = 0.080),但腹腔镜组非肝脏特异性并发症发生率更低(p = 0.025)。
  • 美国麻醉医师协会分级>II级、BMI>30 kg/m²和恶性肿瘤是并发症的独立预测因素。
  • 肝细胞癌亚组中,腹腔镜组与开腹组总生存无显著差异(风险比0.225;95%置信区间0.049-1.047;p = 0.057),无复发生存亦无显著差异(风险比0.761;95%置信区间0.394-1.417;p = 0.417)。

临床怎么用

  • 对于高BMI(>25.0 kg/m²)需行大范围肝切除的患者,腹腔镜手术在出血量和术后住院时间方面可能优于开腹手术。
  • 对于BMI>30 kg/m²且合并疾病的恶性肿瘤患者,行腹腔镜大范围肝切除时应特别关注并发症风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the recent rapid increase in the prevalence of obesity, the number of obese patients requiring liver resection, including laparoscopy, has increased. Accordingly, evaluating the outcome of laparoscopic liver resection in obese patients is increasingly important. This study aimed to compare the safety and feasibility of laparoscopic major liver resection (LMR) and open major liver resection (OMR) in patients with a high body mass index (BMI > 25.0 kg/m2). METHODS: We reviewed 521 patients with high BMI (> 25.0 kg/m2) who underwent major liver resection for various indications between January 2009 and November 2018 at Asan Medical Center. We performed 1:1 propensity score matching of the LMR and OMR groups, with 120 patients subsequently included in each group. RESULTS: LMR was associated with lower blood loss and shorter postoperative hospital stays (p < 0.001). Although there was no significant difference in overall complications (p = 0.080), non-liver-specific complications were observed less frequently after LMR (p = 0.025). American Society of Anesthesiologists class > II, BMI > 30 kg/m2, and malignancy were independent predictors of morbidity. In a subgroup analysis of patients with hepatocellular carcinoma, there was no significant difference between the two groups in overall survival (hazard ratio 0.225; 95% confidence interval 0.049-1.047; p = 0.057) and recurrence-free survival (hazard ratio 0.761; 95% confidence interval 0.394-1.417; p = 0.417). CONCLUSIONS: Obesity should not be considered a contraindication for major liver resection using a laparoscopic approach; however, when applying this approach for resecting malignancies in patients with a BMI > 30 kg/m2 and comorbid diseases, special attention should be paid to the possibility of complications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Yoon YI, Kim KH, Cho HD, et al. Operative and long-term oncologic outcomes of laparoscopic versus open major liver resection in patients with a high body mass index (> 25 kg/m2): a propensity score matching analysis. Surg Endosc. 2022. PMID: 35298705. doi:10.1007/s00464-022-09114-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。